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Clinical PerspectiveWhat Is New?The role of echocardiography in the management of acute stroke among African populations has not been well studied.Nine of 10 patients with acute stroke of African descent had abnormal left ventricular geometry and a third had left ventricular systolic dysfunctions.Patients with acute stroke with severe left ventricular systolic function were 3 times at risk of 1‐month mortality.What Are the Clinical Implications?Routine echocardiographic diagnosis and management of cardiac dysfunction during acute stroke may be helpful in preventing worse outcome.

Introduction {#jah33941-sec-0008}
============

Africa is undergoing sociodemographic and lifestyle changes leading to epidemiological transition, which is currently driving an increased burden of stroke in the region.[1](#jah33941-bib-0001){ref-type="ref"}, [2](#jah33941-bib-0002){ref-type="ref"} Ischemic stroke includes cardioembolic stroke and accounts for about 20% of all strokes.[3](#jah33941-bib-0003){ref-type="ref"}, [4](#jah33941-bib-0004){ref-type="ref"} While atrial fibrillation, which accounts for half of all cardioembolic strokes[5](#jah33941-bib-0005){ref-type="ref"} can be diagnosed with electrocardiography, other nonarrhythmic cardioembolic diseases and cryptogenic stroke require echocardiography. Although transesophageal echocardiography is more sensitive in excluding intracardiac/left atrial appendage clot in cardioembolic stroke, transthoracic echocardiography is more widely available and is more commonly used in low‐resource settings such as sub‐Saharan Africa.[6](#jah33941-bib-0006){ref-type="ref"} Certain transthoracic echocardiography features such as left atrial volume, spontaneous echo contrast or "smoke," increased left ventricular (LV) mass, and poor LV functions have been previously associated with stroke and stroke outcome.[7](#jah33941-bib-0007){ref-type="ref"} Early detection of these conditions may be of therapeutic value in the management of stroke. Despite the aforementioned, the current recommendations for the management of acute stroke does not consider echocardiography as an essential test in patients with stroke.[8](#jah33941-bib-0008){ref-type="ref"} This may be the result of global dearth of data on the usefulness of echocardiography in the management of stroke. Therefore, the purpose of this study was to describe the pattern of echocardiographic abnormalities and predictors of outcome in a large cohort of indigenous Africans with acute stroke.

Methods {#jah33941-sec-0009}
=======

Study Design {#jah33941-sec-0011}
------------

The SIREN (Stroke Investigative Research and Education Network) study is a multicenter case‐control investigation that involves 15 sites in Ghana and Nigeria. The details of the study protocol have been published elsewhere.[9](#jah33941-bib-0009){ref-type="ref"} Participants who were 18 years and older with clinical (within 8 days of current symptoms onset) and radiological evidence of stroke were consecutively recruited. Using a pretested case report form completed by trained research assistants and clinicians, basic demographic and lifestyle data including ethnic origin of the participants, socioeconomic status, and anthropometric measurements were obtained. The current analysis was restricted to 1020 participants with stroke who completed echocardiographic assessment at baseline. We used validated instruments such as the Stroke Levity Scale, modified Rankin Scale (mRS), modified National Institute of Health Stroke Scale (NIHSS), and Barthel Index to assess stroke outcome. In this report, 30‐day functional outcome was measured using the mRS. Poor outcome was defined as an mRS \>3. Lipid profile and other clinical and laboratory information were obtained according to the SIREN protocol.[9](#jah33941-bib-0009){ref-type="ref"}

Metabolic syndrome was defined according to International Diabetic Federation criteria by the presence of waist circumference ≥94 cm in men and ≥80 cm in women and any 2 of the following characteristics: triglycerides ≥150 mg/dL, high‐density lipoprotein cholesterol \<40 mg/dL in men and \<50 mg/dL in women, blood pressure ≥130/85 mm Hg, and fasting glucose ≥100 mg/dL.

Echocardiography {#jah33941-sec-0012}
----------------

Experienced cardiologists at the participating centers performed transthoracic echocardiographic examination of patients in a partial left lateral decubitus position using machines equipped with a 3.5‐MHz transducer. Standard echocardiographic measurements were obtained in accordance with the guidelines of the American Society of Echocardiography (ASE) and European Association of Cardiovascular Imaging.[10](#jah33941-bib-0010){ref-type="ref"} Two‐dimensional guided M‐mode echocardiograms were obtained according to the recommendations of the committee on M‐mode standardization of the ASE.[11](#jah33941-bib-0011){ref-type="ref"} Left atrial end‐systolic diameter was assessed from the trailing edge of the posterior aortic--anterior left atrial complex.[12](#jah33941-bib-0012){ref-type="ref"}, [13](#jah33941-bib-0013){ref-type="ref"}

LV mass was calculated using the formula of Devereux and Reichek[14](#jah33941-bib-0014){ref-type="ref"}: LV mass=0.8{1.04 \[(IVS+LVIDd+PWTd)^3^−(LVIDd)^3^\]}+0.6; where LVIDd=LV internal diameter in end diastole, PWTd=LV posterior wall thickness in end diastole, and IVSTd=interventricular septal wall thickness in end diastole. Measurements from this closely related to autopsy measurements (*r*=0.90)[15](#jah33941-bib-0015){ref-type="ref"} and showed good interobserver reproducibility (ρ=0.93) in one study.[16](#jah33941-bib-0016){ref-type="ref"}

LV mass index (LVMI) was calculated by dividing the value of LV mass by height to its allomeric growth rate of 2.7.[17](#jah33941-bib-0017){ref-type="ref"}, [18](#jah33941-bib-0018){ref-type="ref"} The partition value of 51 g/height^2.7^ was used since this was the only criterion that was demonstrated as the optimal threshold value for LV hypertrophy in blacks irrespective of sex in 2 previous studies.[19](#jah33941-bib-0019){ref-type="ref"}, [20](#jah33941-bib-0020){ref-type="ref"}

Relative wall thickness (RWT) was derived from 2×posterior wall thickness/LV end‐diastolic internal diameter. Increased RWT was considered to be present when RWT exceeded 0.42. This represents the 97.5th percentile in normal patients.[21](#jah33941-bib-0021){ref-type="ref"} LV geometry was stratified using LVMI and RWT. Normal geometry was defined as normal LVMI and RWT, concentric remodeling as normal LVMI and increased RWT, eccentric hypertrophy as increased LVMI and RWT \<0.45, and concentric hypertrophy as increased LVMI and RWT ≥0.45.

LV dimensions and systolic function (ejection fraction \[EF\] and fractional shortening) were derived from 2‐dimensional--guided M‐mode measurements and, where impossible as a result of regional wall motion abnormalities, the modified Simpson\'s method was used in assessing LV systolic function. The degree of LV systolic dysfunction has been classified according to ASE guidelines as normal range (52 to 72), mildly abnormal (41 to 51), moderately abnormal (30 to 40), and severely abnormal (\<30) for men, while normal range (54 to 74), mildly abnormal (41 to 53), moderately abnormal (30 to 40), and severely abnormal (\<30) for women.[22](#jah33941-bib-0022){ref-type="ref"}

We also assessed for presence of valvular dysfunction by semiquantitative method according to international guidelines.[23](#jah33941-bib-0023){ref-type="ref"}, [24](#jah33941-bib-0024){ref-type="ref"} Other abnormalities assessed for included presence of pericardial effusion and interventricular and interatrial abnormalities (asymmetric wall motion abnormalities, septal defects, presence of patent foramen ovale, interatrial septal aneurysm).

Measurements were obtained in up to 3 cardiac cycles according to the ASE convention.[11](#jah33941-bib-0011){ref-type="ref"}

Experienced cardiologists performed all echocardiography in the various centers; intraobserver concordance correlation coefficient and measurement error have been reported.[25](#jah33941-bib-0025){ref-type="ref"}, [26](#jah33941-bib-0026){ref-type="ref"}

Data Management and Statistical Analysis {#jah33941-sec-0013}
----------------------------------------

We reported mean and SD or median and interquartile range (IQR) for continuous variables, and categorical variables were summarized using counts and percentages. These descriptive measures were reported by sex (male versus female) and stroke type (ischemic versus hemorrhagic). Comparisons between these categories were performed using the 2‐sample *t* test for continuous variables or Mann--Whitney *U* test depending on whether the variable was symmetrical (normally distributed) or not. Chi‐square test was employed for categorical variables. To explore the relationship between echocardiographic parameters and 1‐month disability and fatality, univariate and multivariable generalized linear models were fitted. In order to obtain relative risk (RR), which is the appropriate measure for a prospective study, a generalized linear model with binomial distribution and log‐link function was employed. Both unadjusted RRs and adjusted RRs were computed and reported with their corresponding 95% CIs. Predictive model was fitted separately for 1‐month disability and fatality using backward selection with removal of *P* value set at 0.20. Goodness of fit of the final model was assessed using residual analysis and Hosmer‐Lemeshow test. To assess the predictive power of the fitted model, cross‐validation was performed and area under the receiver operating characteristic curve (AUC) was estimated with its 95% CI.[27](#jah33941-bib-0027){ref-type="ref"} Statistical significance was assessed at a level of 0.05. Analysis was performed using Stata MP version 14 (StataCorp).[28](#jah33941-bib-0028){ref-type="ref"}

Ethical Approval {#jah33941-sec-0014}
----------------

Ethical approval for the study was obtained from the joint University of Ibadan/University College Hospital ethical review committee as the primary site and institutional review board of each other participating institution. Informed consent was obtained from each participant.

Results {#jah33941-sec-0015}
=======

Clinical and Echocardiographic Characteristics of the Study Population {#jah33941-sec-0016}
----------------------------------------------------------------------

A total of 1020 patients with stroke comprising 60% men with mean age of 59.2±14.6 years were studied (Tables [1](#jah33941-tbl-0001){ref-type="table"} and [2](#jah33941-tbl-0002){ref-type="table"}). Women were heavier, with higher mean waist circumference and total and low‐density lipoprotein cholesterol levels. Forty‐three percent of the participants had metabolic syndrome, with a female preponderance (61.5% versus 29.8%, *P*=0.001). Compared with ischemic stroke, hemorrhagic stroke occurred in younger ages, was more common in men, and was associated with higher mean systolic blood pressure, diastolic blood pressure, mean arterial pressure, and prevalence of hypertension (86.3% versus 72.6%; *P*\<0.001) Table [2](#jah33941-tbl-0002){ref-type="table"}.

###### 

Demographic and Clinical Characteristics According to Sex

  Variables                                         All Participants (N=1020)   Men (n=608)    Women (n=412)   *P* Value
  ------------------------------------------------- --------------------------- -------------- --------------- ------------------------------------------------
  Mean age, y                                       59.2 (14.6)                 59.0 (13.9)    59.6 (15.5)     0.473
  Education, %                                                                                                 
  No formal education                               15.3                        7.5            26.6            0.001[a](#jah33941-note-0101){ref-type="fn"}
  Primary                                           20.5                        18.5           23.4            
  Secondary                                         27.5                        28.7           25.6            
  Higher                                            36.7                        45.2           24.4            
  Height, m                                         1.66 (0.08)                 1.69 (0.07)    1.62 (0.074)    0.001[a](#jah33941-note-0101){ref-type="fn"}
  Weight, kg                                        73.5 (14.4)                 73.9 (13.5)    72.8 (15.6)     0.331
  BMI, kg/m^2^                                      26.6 (5.26)                 25.8 (4.66)    27.8 (5.87)     0.001[a](#jah33941-note-0101){ref-type="fn"}
  Systolic BP, mean (SD), mm Hg                     155.0 (30.06)               155.0 (29.8)   155.0 (30.5)    0.979
  Diastolic BP, mean (SD), mm Hg                    93.9 (18.3)                 94.7 (18.8)    92.7 (17.4)     0.097
  Hypertension, %                                   75.3                        76             74.3            0.533
  Diabetes mellitus, %                              13                          13             13.1            0.958
  Dyslipidemia, %                                   60.2                        59.7           60.9            0.696
  Stroke type, %                                                                                               
  Ischemic                                          80                          77.9           83              0.049[a](#jah33941-note-0101){ref-type="fn"}
  Hemorrhagic                                       20                          22.1           17              
  Family history of stroke, %                       19.4                        20.1           18.3            0.463
  Metabolic syndrome, %                             42.5                        29.8           61.5            \<0.001[a](#jah33941-note-0101){ref-type="fn"}
  Waist circumference, cm                           90.2 (14.0)                 88.8 (12.7)    92.3 (15.5)     0.0002[a](#jah33941-note-0101){ref-type="fn"}
  Triglyceride, mg/dL                               133.9 (96.7)                133.8 (96.6)   134.3 (97.0)    0.937
  Total cholesterol, mg/dL                          193.4 (52.3)                188.1 (56.8)   200.9 (62.0)    0.0015[a](#jah33941-note-0101){ref-type="fn"}
  HDL cholesterol, mg/dL                            50.3 (22.5)                 48.7 (24.2)    52.6 (19.7)     0.022[a](#jah33941-note-0101){ref-type="fn"}
  LDL cholesterol, mg/dL                            121.0 (50.4)                117.1 (46.0)   126.4 (55.6)    0.0081[a](#jah33941-note-0101){ref-type="fn"}
  Lipids ratio: total cholesterol/HDL cholesterol   4.46 (2.23)                 4.58 (2.34)    4.29 (2.08)     0.091
  Lipids ratio: total cholesterol/LDL cholesterol   1.75 (0.62)                 1.76 (0.66)    1.75 (0.57)     0.799

BMI indicates body mass index; BP, blood pressure; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein.

*P*\<0.05.

###### 

Clinical Characteristics According to Stroke Type

  Variables                  Ischemic (n=814)   Hemorrhagic (n=204)   *P* Value
  -------------------------- ------------------ --------------------- ------------------------------------------------
  Mean age, y                60.5 (14.7)        54.0 (13.0)           \<0.001[a](#jah33941-note-0102){ref-type="fn"}
  Sex, %                                                              
  Male                       58.1               65.7                  0.049[a](#jah33941-note-0102){ref-type="fn"}
  Female                     41.9               34.3                  
  Education, %                                                        
  No formal education        11.9               11.2                  0.09
  Primary                    18.8               19.2                  
  Secondary                  34.2               34.6                  
  Higher                     35.1               35.1                  
  Height, m                  1.66 (0.078)       1.67 (0.087)          0.5074
  Weight, kg                 73.2 (14.7)        74.9 (14.4)           0.2179
  BMI, kg/m^2^               26.5 (5.28)        27.0 (5.57)           0.3346
  Mean systolic BP, mm Hg    151.8 (29.2)       167.7 (29.1)          \<0.001[a](#jah33941-note-0102){ref-type="fn"}
  Mean diastolic BP, mm Hg   91.6 (17.3)        102.7 (18.7)          \<0.001[a](#jah33941-note-0102){ref-type="fn"}
  MAP, mm Hg                 90.8 (21.7)        99.2 (22.1)           \<0.001[a](#jah33941-note-0102){ref-type="fn"}
  PP, mean, mm Hg            60.2 (19.6)        65.0 (20.6)           0.0039[a](#jah33941-note-0102){ref-type="fn"}
  Hypertension, %            72.6               86.3                  \<0.001[a](#jah33941-note-0102){ref-type="fn"}
  Diabetes mellitus, %       13.8               9.8                   0.133
  Dyslipidemia, %            61.6               54.4                  0.063

BMI indicates body mass index; BP, blood pressure; MAP, mean arterial pressure; PP, pulse pressure.

*P*\<0.05.

LV Structure and Functions {#jah33941-sec-0017}
--------------------------

Echocardiographic features varied across sex and stroke types (Tables [3](#jah33941-tbl-0003){ref-type="table"} and [4](#jah33941-tbl-0004){ref-type="table"}). Male participants had larger mean aortic root diameter (*P*\<0.0001), LV internal dimension at systole (*P*\<0.0377) and diastole (*P*\<0.0001), and septal wall thickness at systole (*P*=0.0007). A greater proportion of women than men had left atrial enlargement (21.4% versus 16.6%; *P*=0.006). Ischemic stroke was associated with smaller aortic root diameter, septal and posterior wall thickness at systole, and poorer LV systolic function. Spontaneous echo contrast and abnormal wall motion abnormalities were more common among patients with ischemic stroke. Over 90% of patients with stroke had associated abnormal LV geometry with eccentric hypertrophy predominating. Abnormal LV geometry was worse in men than women and patients with hemorrhagic versus ischemic stroke.

###### 

Echocardiographic Parameters According to Sex

  Variables, Mean (SD), mm              All Participants (N=1020)   Men (n=608)     Women (n=412)   *P* Value
  ------------------------------------- --------------------------- --------------- --------------- ----------------------------------------------
  Left atrial diameter                  29.7 (20.3)                 30.3 (23.5)     28.9 (14.2)     0.295
  Aortic root diameter                  30.6 (11.6)                 31.9 (14.5)     28.5 (4.4)      0.000[a](#jah33941-note-0103){ref-type="fn"}
  Aortic valvular opening               19.2 (7.3)                  20.1 (8.8)      17.8 (3.6)      0.000[a](#jah33941-note-0103){ref-type="fn"}
  LVID                                  44.0 (9.9)                  45.8 (10.1)     41.4 (8.9)      0.000[a](#jah33941-note-0103){ref-type="fn"}
  LVIDs                                 32.2 (29.1)                 33.9 (33.2)     29.7 (21.2)     0.038[a](#jah33941-note-0103){ref-type="fn"}
  IVSTD                                 14.6 (8.1)                  14.9 (7.8)      14.2 (8.6)      0.198
  IVSTS                                 17.3 (5.5)                  17.8 (6.0)      16.5 (4.6)      0.000[a](#jah33941-note-0103){ref-type="fn"}
  LVPWTD                                14.5 (7.4)                  14.6 (7.4)      14.3 (7.5)      0.668
  LVPWTS                                19.5 (11.5)                 19.3 (10.2)     19.9 (13.3)     0.427
  EF, %                                 62.2 (30.8)                 61.2 (31.6)     63.6 (29.6)     0.234
  FS, %                                 35.2 (24.0)                 33.5 (16.3)     37.8 (32.2)     0.007[a](#jah33941-note-0103){ref-type="fn"}
  LVM, g                                240.0 (108.3)               261.2 (113.7)   207.7 (90.5)    0.000[a](#jah33941-note-0103){ref-type="fn"}
  LVM/height^2.7^                       61.6 (27.0)                 64.5 (26.8)     57.1 (26.8)     0.000[a](#jah33941-note-0103){ref-type="fn"}
  LVH, %                                62.1                        66.3            55.5            0.006[a](#jah33941-note-0103){ref-type="fn"}
  LV wall motion abnormality, No. (%)   137 (15.4)                  88 (16.5)       49 (13.8)       0.292
  Pericardial effusion, No. (%)         83 (9.5)                    55 (10.4)       28 (8.1)        0.252
  Mitral valve disease, No. (%)         128 (12.6)                  84 (13.8)       44 (10.7)       0.143
  Aortic valve disease, No. (%)         97 (9.5)                    64 (10.5)       33 (8.1)        0.184
  Spontaneous echo contrast, No. (%)    58 (6.3)                    43 (7.8)        15 (4.1)        0.022[a](#jah33941-note-0103){ref-type="fn"}
  Intracardiac clots, No. (%)           11 (1.2)                    4 (0.7)         7 (1.9)         0.128
  LV geometry, %                                                                                    
  Normal                                9.4                         8.9             10.3            0.053[a](#jah33941-note-0103){ref-type="fn"}
  Concentric remodeling                 25.3                        22.1            30.2            
  Concentric hypertrophy                9.1                         10.6            6.9             
  Eccentric hypertrophy                 56.1                        58.4            52.7            
  LV systolic dysfunction, %                                                                        
  None                                  68.3                        67.6            69.4.           0.362
  Mild                                  20.7                        19.9            22              
  Moderate                              6.3                         7.0             5.3             
  Severe                                4.7                         5.5             3.4             
  Left atrial enlargement, %                                                                        
  None                                  81.5                        83.4            78.6            0.006
  Mild                                  12.6                        12.2            13.1            
  Moderate                              3.9                         3.5             4.3             
  Severe                                2.1                         0.9             4               

EF indicates ejection fraction; FS, fractional shortening; IVSTD, interventricular septal thickness at end diastole; IVSTS, interventricular septal thickness at end systole; LV, left ventricular; LVH, left ventricular hypertrophy; LVID, left internal dimension at diastole; LVIDs, left internal dimension at systole; LVM, left ventricular mass; LVPWTD, left ventricular posterior wall thickness at diastole; LVPWTS, left ventricular posterior wall thickness at systole.

*P*\<0.05.

###### 

Echocardiographic Parameters According to Stroke Type

  Variables, Mean (SD), mm             Ischemic (n=814)   Hemorrhagic (n=204)   *P* Values
  ------------------------------------ ------------------ --------------------- ----------------------------------------------
  Left atrial diameter                 29.5 (13.1)        29.9 (14.9)           0.991
  Aortic root diameter                 30.2 (7.2)         32.5 (22.7)           0.018[a](#jah33941-note-0104){ref-type="fn"}
  Aortic valvular opening              18.9 (4.1)         19.0 (4.3)            0.805
  LVID                                 44.2 (9.9)         42.6 (10.2)           0.062
  LVIDs                                32.5 (30.9)        29.9 (22.9)           0.292
  IVSTD                                14.4 (8.2)         15.4 (7.8)            0.192
  IVSTS                                16.8 (5.3)         19.1 (5.4)            0.000[a](#jah33941-note-0104){ref-type="fn"}
  LVPWTD                               14.2 (7.7)         14.8 (4.7)            0.2663
  LVPWTS                               18.9 (11.9)        21.5 (10.4)           0.004[a](#jah33941-note-0104){ref-type="fn"}
  EF, %                                59.7 (15.6)        62.9 (15.4)           0.009[a](#jah33941-note-0104){ref-type="fn"}
  FS, %                                32.9 (11.3)        35.0 (11.4)           0.029[a](#jah33941-note-0104){ref-type="fn"}
  LVM, g                               236.5 (106.7)      254.7 (113.9)         0.059
  LVM/height^2.7^                      60.6 (26.5)        65.4 (28.6)           0.063
  LVH, %                               61.1               65.4                  0.356
  Wall motion abnormality, No. (%)     107 (15.1)         30 (16.8)             0.576
  Pericardial effusion, No. (%)        66 (9.4)           17 (10.1)             0.759
  Mitral valve disease, No. (%)        107 (13.1)         21 (10.3)             0.282
  Aortic valve disease, No. (%)        79 (9.7)           18 (8.9)              0.716
  Spontaneous echo contrast, No. (%)   37 (5.0)           21 (11.4)             0.002[a](#jah33941-note-0104){ref-type="fn"}
  Intracardiac clots, No. (%)          9 (1.2)            2 (1.1)               0.614
  LV geometry, %                                                                
  Normal                               10.6               5                     0.015[a](#jah33941-note-0104){ref-type="fn"}
  Concentric remodeling                25.1               25.9                  
  Concentric hypertrophy               10.4               4.3                   
  Eccentric hypertrophy                53.9               64.8                  
  LV systolic dysfunction, %                                                    
  None                                 67.8               70.8                  0.741
  Mild                                 20.7               20.8                  
  Moderate                             6.6                4.9                   
  Severe                               4.9                3.5                   

EF indicates ejection fraction; FS, fractional shortening; IVSTD, interventricular septal thickness at end diastole; IVSTS, interventricular septal thickness at end systole; LV, left ventricular; LVH, left ventricular hypertrophy; LVID, left internal dimension at diastole; LVIDs, left internal dimension at systole; LVM, left ventricular mass; LVPWTD, left ventricular posterior wall thickness at diastole; LVPWTS, left ventricular posterior wall thickness at systole.

*P*\<0.05.

Predictors of 1‐Month Disability and Fatality {#jah33941-sec-0018}
---------------------------------------------

After adjusting for variables that had significant bivariate association, age was an independent predictor of 1‐month disability and fatality (Tables [5](#jah33941-tbl-0005){ref-type="table"} and [6](#jah33941-tbl-0006){ref-type="table"}). Patients 60 years and older had a higher risk of having disability (adjusted RR, 1.42; 95% CI, 1.06--1.88) and fatality (adjusted RR, 1.84; 95% CI, 1.06--3.18) compared with younger patients. Women were more likely to have functional disability (unadjusted RR 1.26; 95% CI, 1.05--1.51). While secondary school education was protective, hypertension (unadjusted RR: 1.27; 95% CI, 1.00--1.62) and LV posterior wall thickness were associated with disability (unadjusted RR, 1.08; 95% CI, 1.07--1.069).

###### 

Clinical Features Associated With 1‐Month Disability

  Variables                     Good mRS, (n=−626), %   Poor mRS (n=394), %   Unadjusted Risk Estimates   Adjusted Risk Estimates                                                                      
  ----------------------------- ----------------------- --------------------- --------------------------- ------------------------- ---------------------------------------------- ------ ------------ ------------------------------------------------
  Age (mean), y                 57.7 (13.9)             62.4 (14.4)           1.01                        1.01--1.02                \<0.0001                                       ···    ···          ···
  Age \>60 y                    45.1                    59.4                  1.43                        1.18--7.73                \<0.0001                                       1.42   1.06--1.88   0.017[a](#jah33941-note-0105){ref-type="fn"}
  Sex                                                                                                                                                                                                  
  Male                          61.7                    52.5                                                                                                                                           
  Female                        38.3                    47.5                  1.26                        1.05-- 1.51               0.015[a](#jah33941-note-0105){ref-type="fn"}   1.05   0.80--1.39   0.720
  Education                                                                                                                                                                                            
  No formal education           12.6                    16.4                  1.00                        ···                       ···                                            1.00   ···          ···
  Primary                       15.3                    24.7                  1.12                        0.85--1.47                0.420                                          0.91   0.62--1.33   0.622
  Secondary                     30.8                    23.6                  0.72                        0.54--0.97                0.030[a](#jah33941-note-0105){ref-type="fn"}   0.65   0.42--0.99   0.046[a](#jah33941-note-0105){ref-type="fn"}
  Higher                        41.3                    35.3                  0.78                        059--1.02                 0.068                                          0.77   0.53--1.11   0.163
  Hypertension                  73                      79.7                  1.27                        1.00--1.62                0.047[a](#jah33941-note-0105){ref-type="fn"}   1.22   0.87--1.71   0.246
  Diabetes mellitus             14.3                    9.8                   0.76                        055--1.06                 0.107                                          ···    ···          ···
  Dyslipidemia                  62.5                    67                    1.13                        0.93--1.38                0.216                                          ···    ···          ···
  BMI                           26.8 (5.19)             26.5 (5.41)           0.99                        0.97--1.01                0.425                                          ···    ···          ···
  Echo parameters                                                                                                                                                                                      
  Left atrial diameter          3.07 (2.68)             3.01 (1.26)           0.99                        0.95--1.04                0.808                                          ···    ···          ···
  Aortic root diameter          3.05 (0.76)             3.00 (0.54)           0.93                        0.79--1.10                0.403                                          ···    ···          ···
  Aortic valvular opening, cm   1.99 (0.99)             1.90 (0.47)           0.85                        0.65--1.12                0.261                                          ···    ···          ···
  LVID                          4.44 (0.95)             4.32 (1.06)           0.91                        0.82--1.01                0.082                                          0.99   0.75--1.31   0.977
  LVIDs                         3.18 (1.78)             3.35 (4.65)           1.02                        1.01--1.02                \<0.0001                                       0.97   0.75--1.24   0.789
  IVSTD                         1.45 (0.98)             1.43 (0.58)           0.98                        0.86--1.13                0.828                                          ···    ···          ···
  IVSTS                         1.66 (0.57)             1.69 (0.56)           1.06                        0.88--1.26                0.549                                          ···    ···          ···
  LVPWTD                        1.43 (0.81)             1.53 (0.76)           1.07                        0.97--1.18                00.189                                         ···    ···          ···
  LVPWTS                        1.88 (1.04)             2.17 (1.62)           1.08                        1.07--1.069               0.010[a](#jah33941-note-0105){ref-type="fn"}   1.11   1.07--1.15   \<0.001[a](#jah33941-note-0105){ref-type="fn"}
  EF, %                         63.0 (27.3)             61.9 (34.7)           0.99                        0.99--1.00                1.00                                           ···    ···          ···
  EF \<50%                      16.9                    20.4                  1.15                        0.91--1.44                0.248                                          ···    ···          ···
  FS, %                         34.0 (11.4)             36.2 (28.6)           1.00                        0.98--1.01                0.989                                          ···    ···          ···
  LVM indexed by height         244.5 (107.8)           237.9 (108.2)         0.99                        0.99--1.01                0.800                                          ···    ···          ···
  Abnormal LVM                  63.6                    63.0                  0.98                        0.72--1.34                0.915                                          ···    ···          ···
  LV geometry                                                                                                                                                                                          
  Normal                        14                      7.7                   1.00                        ···                       ···                                            1.00   ···          ···
  Concentric remodeling         23.5                    26.8                  1.66                        0.98--2.82                0.062                                          1.35   0.74--2.47   0.325
  Concentric hypertrophy        7.3                     9.5                   1.80                        0.97--5.73                0.058                                          1.77   0.89--3.52   0.103
  Eccentric hypertrophy         55.2                    56                    1.54                        0.94--3.56                0.095                                          1.48   0.86--2.55   0.158
  LV systolic dysfunction                                                                                                                                                                              
  None                          72.8                    69.1                  1.00                        ···                       ···                                            ···    ···          ···
  Mild                          18.6                    20.7                  1.17                        0.92--1.48                0.207                                          ···    ···          ···
  Moderate                      5.7                     6                     1.11                        0.81--1.52                0.529                                          ···    ···          ···
  Severe                        3                       4.2                   1.30                        0.80--2.12                0.292                                          ···    ···          ···

BMI indicates body mass index; EF, ejection fraction; FS, fractional shortening; IVSTD, interventricular septal thickness at end diastole; IVSTS, interventricular septal thickness at end systole; LV, left ventricular; LVID, left internal dimension at diastole; LVIDs, left internal dimension at systole; LVM, left ventricular mass; LVPWTD, left ventricular posterior wall thickness at diastole; LVPWTS, left ventricular posterior wall thickness at systole; mRS, modified Rankin Scale; RR, relative risk.

*P*\<0.05.

###### 

Clinical Characteristics by 1‐Month Fatality

  Variables                    No Fatality (n=926)   Fatality (n=94)   Unadjusted Risk Estimates   Adjusted Risk Estimates                                                                      
  ---------------------------- --------------------- ----------------- --------------------------- ------------------------- ---------------------------------------------- ------ ------------ ----------------------------------------------
  Age, mean, y                 59.0 (14.2)           64.2 (14.3)       1.02                        1.01--1.04                0.005[a](#jah33941-note-0007){ref-type="fn"}                       
  Age \>60 y                   49.3                  63.6              1.71                        1.06--2.76                0.029[a](#jah33941-note-0007){ref-type="fn"}   1.84   1.06--3.18   0.029[a](#jah33941-note-0007){ref-type="fn"}
  Sex                                                                                                                                                                                           
  Male                         58.6                  54.6                                                                                                                                       
  Female                       41.4                  45.4              1.16                        0.73--1.84                0.530                                          ···    ···          ···
  Education                                                                                                                                                                                     
  No formal education          13.9                  15.2              1.00                        ···                       ···                                            ···    ···          ···
  Primary                      18.6                  22.7              1.11                        0.52--2.37                0.785                                          ···    ···          ···
  Secondary                    27.9                  30.3              1.00                        0.49--2.05                1.000                                          ···    ···          ···
  Higher                       39.6                  31.8              0.76                        0.37--1.55                0.449                                          ···    ···          ···
  Hypertension                 75                    80.3              1.32                        0.74 to 2.36              0.348                                          ···    ···          ···
  Diabetes mellitus            12.6                  10.6              0.83                        0.39--1.77                0.637                                          ···    ···          ···
  Dyslipidemia                 63.8                  68.2              1.20                        0.73--1.96                0.480                                          ···    ···          ···
  BMI                          26.6 (5.3)            27.8 (4.9)        1.03                        0.98--1.09                0.194                                          ···    ···          ···
  Echo parameters, mean (SD)                                                                                                                                                                    
  Left atrial diameter         3.03 (2.33)           3.21 (0.96)       1.02                        0.95--1.09                0.600                                          ···    ···          ···
  Aortic root diameter         3.03 (0.69)           3.04 (0.55)       1.02                        0.75--1.39                0.894                                          ···    ···          ···
  Aortic valvular opening      1.97 (0.88)           1.88 (0.39)       0.76                        0.39--1.45                0.402                                          ···    ···          ···
  LVID                         4.42 (0.96)           4.21 (1.20)       0.81                        0.64--1.03                0.088                                          0.88   0.67--1.14   0.336
  LVIDs                        3.14 (1.59)           4.22 (9.13)       1.04                        1.03--1.04                \<0.001                                        1.01   0.99--1.03   0.394
  IVSTD                        1.44 (0.86)           1.55 (0.86)       1.09                        0.89--1.35                0.384                                          ···    ···          ···
  IVSTS                        1.67 (0.55)           1.69 (0.71)       1.09                        0.72--1.65                0.687                                          ···    ···          ···
  LVPWTD                       1.46 (0.81)           1.48 (0.59)       1.03                        0.77--1.36                0.850                                          ···    ···          ···
  LVPWTS                       1.98 (1.30)           2.13 (1.34)       1.06                        0.92--1.23                0.412                                          ···    ···          ···
  EF, %                        61.5 (15.3)           57.9 (15.6)       0.99                        0.97--1.00                0.060                                          0.98   0.94--1.01   0.228
  EF \<50%                     17.5                  25.8              1.56                        0.92--2.67                0.102                                                              
  FS, %                        34.0 (11.4)           31.9 (12.1)       0.98                        0.96--1.01                0.154                                          ···    ···          ···
  LVM indexed by height        62.7 (28.8)           55.9 (24.7)       1.00                        0.97--1.01                0.520                                          ···    ···          ···
  Abnormal LVM                 63.8                  58.3              0.81                        0.37--1.76                0.594                                          ···    ···          ···
  LV geometry                                                                                                                                                                                   
  Normal                       12.3                  6.7               1.00                        ···                       ···                                            ···    ···          ···
  Concentric remodeling        24.4                  26.7              1.92                        0.56--6.52                0.298                                          ···    ···          ···
  Concentric hypertrophy       8                     8.9               1.95                        0.46--8.22                0.364                                          ···    ···          ···
  Eccentric hypertrophy        55.3                  57.8              1.84                        0.58--5.88                0.302                                          ···    ···          ···
  LV systolic dysfunction                                                                                                                                                                       
  None                         72.2                  93                1.00                        ···                       ···                                            1.00   ···          ···
  Mild                         19.3                  20.4              0.77                        0.37--1.60                0.488                                          0.56   0.20--1.38   0.191
  Moderate                     5.6                   7.4               1.38                        0.68--2.82                0.372                                          0.71   0.20--2.49   0.589
  Severe                       2.8                   9.3               3.05                        1.36--6.83                0.007[a](#jah33941-note-0007){ref-type="fn"}   0.96   0.16--5.75   0.968
  Left atrial enlargement      19.9                  14.3              0.69                        0.35--1.36                0.288                                          ···    ···          ···

EF indicates ejection fraction; FS, fractional shortening; IVSTD, interventricular septal thickness at end diastole; IVSTS, interventricular septal thickness at end systole; LV, left ventricular; LVID, left internal dimension at diastole; LVIDs, left internal dimension at systole; LVM, left ventricular mass; LVPWTD, left ventricular posterior wall thickness at diastole; LVPWTS, left ventricular posterior wall thickness at systole; RR, relative risk.

*P*\<0.05.

Abnormal LV geometry was weakly associated with disability, with concentric hypertrophy having the strongest effect size (unadjusted RR, 1.80; 95% CI, 0.97--5.73). After cross‐validation, the AUC for disability was 0.58 (95% CI, 0.52--0.64). Severe LV systolic dysfunction was associated with 1‐month mortality (unadjusted RR, 3.05; 95% CI, 1.36--6.83). The AUC obtained from cross‐validation was 0.56 (95% CI, 0.52--0.64).

Discussion {#jah33941-sec-0019}
==========

This study demonstrated the clinical risk factor profile for stroke as earlier reported.[29](#jah33941-bib-0029){ref-type="ref"}, [30](#jah33941-bib-0030){ref-type="ref"} Low LVEF, sex, and age were independently associated with poor stroke outcome.

LV systolic dysfunction as defined by low EF has been shown in several studies to be a strong determinant of stroke outcome.[31](#jah33941-bib-0031){ref-type="ref"} This study revealed that the risk of fatality at 1 month was significantly higher at lower EFs. While some studies have shown significant association with low EF and poor clinical outcome, especially in cardioembolic stroke, others have shown that the association is merely a reflection of old age, increasing cardiac comorbidities, and more severe clinical presentation than the EF alone.[32](#jah33941-bib-0032){ref-type="ref"}, [33](#jah33941-bib-0033){ref-type="ref"} Similar to our findings, Wira et al[31](#jah33941-bib-0031){ref-type="ref"} reported higher in‐hospital mortality rates in patients with stroke with LVEF \<50%. The higher mortality rate may be a result of loss of intrinsic cerebral vascular autoregulation, making cerebral blood flow dependent on cardiac function, which, if poor, will result in reduced cerebral blood flow and poorer outcome.

While findings of association between low EF and worse stroke outcome have been consistent, there are conflicting reports with regard to the predictive accuracy of low EF and mortality. In this study, low EF was associated with 1‐month fatality, with an AUC of 0.56, which is not strong.[34](#jah33941-bib-0034){ref-type="ref"} Similarly in the ASTRAL (Acute Stroke Registry and Analysis of Lausanne) study, despite an increased rate of morbidity and death among patients with stroke with low EF, the AUC was 0.50.[33](#jah33941-bib-0033){ref-type="ref"} In some studies, predictive accuracy of low EF was only improved when combined with the NIHSS and lipid disorders.[35](#jah33941-bib-0035){ref-type="ref"}, [36](#jah33941-bib-0036){ref-type="ref"} Nevertheless, early detection and management of patients with stroke with low EF through routine echocardiography and aggressive treatment of LV dysfunction in patients with acute stroke may improve post‐stroke morbidity and death and prevent stroke recurrence.

The reasons for sex differences in stroke outcomes remain unclear. In this study, men were more prone to functional disability with no difference in mortality at 1 month. This differs from findings from the Fukuoka Stroke Registry in Japan, where women older than 70 years were more prone to poor functional disability but no difference was seen in those younger than 70 years.[37](#jah33941-bib-0037){ref-type="ref"} The reason for worse outcome among men in our study may be partly caused by higher frequency of LV systolic dysfunction among men. In addition, this disparity may be the result of the sex‐specific association, with major cardiovascular risk factors similarly reported in other studies[38](#jah33941-bib-0038){ref-type="ref"}, [39](#jah33941-bib-0039){ref-type="ref"}; hormonal influences; and the effect of Y chromosome on cardiovascular diseases.[40](#jah33941-bib-0040){ref-type="ref"}

Elderly patients experiencing stroke generally have poor functional outcomes afterwards.[41](#jah33941-bib-0041){ref-type="ref"} Our finding of increased risk of functional disability and death among patients older than 60 years was not surprising. Elderly patients were more prone to having atrial fibrillation and poor cardiac function, as well as having a high likelihood comorbid conditions.[42](#jah33941-bib-0042){ref-type="ref"} In another study, biological rather than chronological age was a better predictor of worse stroke outcome.[43](#jah33941-bib-0043){ref-type="ref"} Biological age can be modified by lifestyle and dietary practices such as consumption of green leafy vegetables, which demonstrated a strong protective effect against stroke occurrence and severe stroke.[29](#jah33941-bib-0029){ref-type="ref"}

The clinical significance of LV geometry has been explored in many populations.[44](#jah33941-bib-0044){ref-type="ref"} Despite the increased risk of stroke in the presence of abnormal LV geometry, information on the prognostic implications of LV geometry in patients with ischemic stroke is scanty. This study provides the first data among indigenous Africans on the prognostic role of LV geometric pattern in acute stroke. Over 90% of our study participants had associated abnormal LV geometry with eccentric hypertrophy predominating. Contrary to earlier reports, abnormal LV geometry demonstrated in this study was not associated with worse stroke outcome.[45](#jah33941-bib-0045){ref-type="ref"}, [46](#jah33941-bib-0046){ref-type="ref"} Similar to the current study findings, Field et al[47](#jah33941-bib-0047){ref-type="ref"} in the SPS3 (Secondary Prevention of Small Subcortical Strokes) trial showed that 70% of the participants with lacunar stroke had abnormal LV geometry with no significant association with worse stroke outcome. The reasons for this discrepancy may be a result of our small sample size and short follow‐up duration.

Strengths, Limitations, and Future Direction {#jah33941-sec-0020}
--------------------------------------------

To the best of our knowledge, this is the largest echocardiographic study among indigenous African patients with stroke ever reported.[2](#jah33941-bib-0002){ref-type="ref"} We provide evidence that LV systolic dysfunction on baseline echocardiography is associated with 1‐month outcome in this population. We could not establish whether these factors were independent predictors of outcome because of low predictive accuracy for low EF and abnormal LV geometry (AUC 0.56 and 0.58, respectively). Larger studies are required to establish their independent effects and investigate mediators of such an effect. However, aggressive management of LV systolic dysfunction and abnormal geometry by cardiologists and stroke experts may improve stroke outcome among the identified at‐risk population.

A limitation of our study is our inability to assess diastolic function because of incomplete tissue Doppler imaging data. Follow‐up echocardiography was not obtained in order to document whether the abnormalities were transient.

Given the observed association of age, male sex, low EF, and abnormal geometry with worse outcome, coupled with our earlier reported ECG determinants of stroke outcome,[48](#jah33941-bib-0048){ref-type="ref"} we plan to develop a post‐stroke outcome prediction tool that will be validated for use in people of African ancestry.

Conclusions {#jah33941-sec-0021}
===========

This study demonstrated strong relationships between echocardiographic data and stroke outcome. LV systolic dysfunction may be a useful determinant of outcome in acute stroke among indigenous Africans. Routine echocardiographic diagnosis and management of cardiac dysfunction during acute stroke may be helpful in preventing worse outcome. Larger longitudinal studies are required for confirmation of these findings.
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